PRESENTATION
H1 FY2021 — Results presentation
H1 FY2021PDF · 85 pages16.2 MB
1 1 for the six months ended 31 December 2020 -- 1 of 85 -- 2 +8% including DH take-on of new closed schemes and gross revenue for Vitality Group Core new business API to R9 916m Normalised operating profit to R4 507m Normalised headline earnings to R2 284m COVID-19 provisions Headline earnings to R1 842m unchanged SA COMPOSITE MODEL UK COMPOSITE MODEL PARTNER COMPOSITE MODEL Health Life Invest Robust operating performance with prudent COVID-19 provision Operating model performing well and driving growth, with strength in capital and liquidity A pivot to growth following trends emerging through COVID-19 The businesses well positioned in the four strategic strands -- 2 of 85 -- 3 Claims paid* New cases - 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 07-Jul-19 18-Aug-19 29-Sep-19 10-Nov-19 22-Dec-19 02-Feb-20 15-Mar-20 26-Apr-20 07-Jun-20 19-Jul-20 30-Aug-20 11-Oct-20 22-Nov-20 03-Jan-21 14-Feb-21 - 10,000 20,000 30,000 40,000 50,000 60,000 70,000 07-Jul-19 18-Aug-19 29-Sep-19 10-Nov-19 22-Dec-19 02-Feb-20 15-Mar-20 26-Apr-20 07-Jun-20 19-Jul-20 30-Aug-20 11-Oct-20 22-Nov-20 03-Jan-21 14-Feb-21 New cases Discovery data to date Tests conducted Confirmed positive cases Members admitted *DH: All COVID care on the DHMS scheme for COVID-19 positive members, DL: Individual and Group Risk gross claims, VL: gross claims, VH: Health COVID-19 cash benefit Staff deaths Deaths across DH, DL and VL -- 3 of 85 -- 4 Our strategic response to the pandemic Keep every staff member safe Maintain connectivity Live out our values Ensure business continuity Ensure products are fit-for-purpose Keep people healthy and active Ensure operating profit strong with appropriate and conservative reserve for COVID-19 Minimise the impact on liquidity and solvency Protect the capital plan Maintain financial strength and resilience Support the healthcare system Strengthen the healthcare system Play an outsized role COVID Alert SA app DISCOVERY talks COVID-19 information hub Support our country Protect our people Protect and support our clients Vitality at Home COVID-19 concessions till Dec 20 Wellbeing at Home Oximeter benefit COVID-19 Business Support GP initiated virtual consults SA vaccine programme support Connected Care -- 4 of 85 -- 5 UK’s second wave was a lot more severe on a national level than for VitalityLife, but tapering off Second wave tapering off VitalityLife had higher mortality in the first wave, in FY20 COVID-19 variant more severe Deaths Infections New deaths per day New infections per day UK distribution of strains - 10,000 20,000 30,000 40,000 50,000 60,000 70,000 05-Jan-20 02-Feb-20 01-Mar-20 29-Mar-20 26-Apr-20 24-May-20 21-Jun-20 19-Jul-20 16-Aug-20 13-Sep-20 11-Oct-20 08-Nov-20 06-Dec-20 03-Jan-21 31-Jan-21 - 200 400 600 800 1,000 1,200 1,400 19A 20A 20D 20B 20E 20I/501Y.V1 Mar Jan 20 Jul May Nov Sep Jan 21 COVID-19 infections and deaths More patients in hospital More deaths National wave 2 vs wave 1: 0 1 2 3 4 VL COVID-19 related deaths FY 20 Deaths: H1 21 H2 21 -- 5 of 85 -- 6 SA’s second wave also more severe but rapidly decreasing Higher morbidity Admission rates Fewer out-of-hospital claims Acute medication utilisation Shorter average length of stay OH admissions discharged with oxygen Higher exposure Discovery Life claims paid* (Rm) 0 100 200 300 400 500 600 - 5,000 10,000 15,000 20,000 25,000 Average deaths per day Average new infections per day Daily new infections Avg daily new infections Avg daily new deaths 1.5x peak wave 1 South Africa daily new infection trends SA’s second wave more serious than first, and started in holiday season Comparison between waves using Discovery data Higher socio-economic classes hit harder Deaths DL and DH *Individual and Group Risk gross claims -- 6 of 85 -- 7 Behaviour and a new variant contributed to a second wave -100 -80 -60 -40 -20 0 20 40 Google mobility trends report https://www.google.com/covid19/mobility/ Positive tests per million South Africa distribution of strains, superimposed infection and death rates - 200 400 600 800 1,000 1,200 1,400 20201101 20201106 20201111 20201116 20201121 20201126 20201201 20201206 20201211 20201216 20201221 20201226 20201231 20210105 20210110 20210115 20210120 20210125 20210130 20210204 20210209 16-20 age band Rest of membership higher risk of infection compared to those who didn’t have a flight Dec Mobility increased early December as SA entered holiday season COVID-19 variant 40-50% more transmissible Spike in young infections post-matric celebratory events and spread to other members Mar Jan 20 Jul May Nov Sep Jan 21 20D 20B 20A 0 5 10 0 5 10 15 20 25 30 35 New deaths per million per day New infections per 100,000 per day 20H/501Y.V2 Deaths Infections -- 7 of 85 -- 8 Understanding immunity 0.28% 0.33% 0.39% 85% 70% 59% 51% 90% 74% 62% 54% 95% 78% 66% 57% IFR Excess deaths directly attributable to COVID-19 Expect majority of excess deaths to be due to COVID-19 RSA (natural) excess deaths and reported confirmed COVID-19 deaths Expect 51-57% population infected 20 000 15 000 10 000 5 000 0 -5 000 1 Jan 20 1 Apr 20 1 Jul 20 1 Oct 20 1 Jan 21 Week beginning Excess deaths Reported confirmed COVID-19 deaths https://www.samrc.ac.za/reports/report-weekly-deaths-south-africa Deaths = [ Population infected ] x [ Infection Fatality Rate ] Consistent with SANBS study on the prevalence of COVID antibodies – c52% donors tested positive ∴ Population infected = [ Deaths / Infection Fatality Rate ] -- 8 of 85 -- 9 The blood samples from half the people we tested showed that all neutralising activity was lost. This suggests that they may no longer be protected from reinfection Understanding reinfection rates Discovery Health data suggests very low reinfection risk, even with second variant Reinfections = [ Confirmed positives in wave 1 ] x [ Reinfection rate for those who have recovered ] x [ Probability of testing positive in the second wave ] Confirmed positives in wave 1, recovered more than 90 days prior to wave 2 Vulnerable to reinfection in wave 2 (assume one third) Risk of positive test in wave 2 in DSY Health 2.7% Actual reinfections Source: The evolving science behind long COVID https://mg.co.za/news/2021-01-19-can-you-get-reinfected-with-covid-19-sa-has-4-000-potential-reinfections/ https://www.washingtonpost.com/health/2021/02/05/virus-variant-reinfection-south-africa/ Neutralising antibodies are about a third less by 6 months after hospitalisation Professor Clive Gray Concerns about reinfection rates National Health Laboratory Service In the placebo group of the trial for Novavax’s vaccine, people with prior coronavirus infections appeared just as likely to get sick as people without them, meaning they weren’t fully protected against the B.1.351 variant that has swiftly become dominant in South Africa Washington Post Discovery Health data suggest 28% are vulnerable to reinfection -- 9 of 85 -- 10 Factors that influence COVID-19 waves (1-Immunity) x P(contact) x Risk index COVID Wave = Herd immunity Reinfection rates Vaccines Behaviour COVID-19 variants Community prevalence Resilience index -- 10 of 85 -- 11 Incremental deaths under the medium scenario Scenarios assume IFR = 0.39% and 1/3 reinfection - 200 400 600 800 1,000 1,200 1,400 1,600 1,800 2,000 20200201 20200221 20200312 20200401 20200421 20200511 20200531 20200620 20200710 20200730 20200819 20200908 20200928 20201018 20201107 20201127 20201217 20210106 20210126 20210215 20210307 20210327 20210416 20210506 20210526 20210615 20210705 20210725 20210814 20210903 20210923 20211013 20211102 20211122 20211212 The likelihood of a third wave Projected deaths vs second wave deaths Feb-Jun 0x 0.6x 0.2x Second wave run-off Super spreader at Easter, with reinfections Super spreader at Easter, with reinfections, but with vaccine rollout Jul-Dec 0.2x 0.4x 0.3x Total expected deaths 16.6k 92.5k 44.4k -- 11 of 85 -- Robust operating performance with prudent COVID-19 provision 1 -- 12 of 85 -- 13 1 670 +6% 3 167 -5% 1 922 +3% 1 162 -6% 471 -3% 1 316 -3% 107 +43% 617 +12% SA Composite2 4 170 +5% 6 262 -4% 613 +24% 638 +4% 327 +206% 561 -13% UK Composite2 940 +56% 1 199 -5% 238 +116% 625 +21% 112 +65% 1 805 +31% New businesses (999) +0% 1 005 +169% Rm SA Composite UK Composite Partner Composite Excludes SA Vitality 1 Including new closed schemes 2 Excluding New initiatives Operating profit R4.5bn New business R10.9bn Health insurance Life insurance Continued operational excellence with significant support to members and society Excellent operating performance and positive variances delivering growth on an optimised capital base High-quality earnings driven by positive flows and market growth albeit in difficult market conditions Strong new business and retention dynamics driving growth with consistently expanding margins and proven efficacy of the model Excellent performance driven by continued retention and proven relevance of the model Robust recovery with positive lapse experience and resilience to interest rate volatility Global relevance gaining significant traction with excellent operating performance and considerable effect on our partners Continuation of remarkable revenue, new business and profit growth Prudent Bank rollout pivoting towards growth, with other segments gaining further traction 1 -- 13 of 85 -- 14 30-Jun-20 Claims and lapse unwind Net new and new business COVID-19 provisions* 31-Dec-20 30-Jun-20 Net movement in claims and lapses New business COVID-19 provision Additional claims provision 31-Dec-20 COVID-19 provisions back to R3.4bn in December 2020 *GBP11.7m released from COVID provision used to strengthen long-term lapse assumptions and net movements in UPR Health insurance Life insurance £69.8m £64.9m R2 160m R1 953m 1 023 lapses 956 claims Invest Invest DL claims reserve at the end of January can cover a 3rd wave ~ equal to the 1st wave, plus the lapse provision -- 14 of 85 -- 15 Currency and interest rates volatile over the period Rapid strengthening of the rand Sustained elevated long-term interest rates in SA in USD average vs Dec 19 12 14 16 18 20 22 24 26 Dec-31 Jan 16 Feb 01 Feb 17 Mar 04 Mar 20 Apr 05 Apr 21 May 07 May 23 Jun 08 Jun 24 Jul 10 Jul 26 Aug 11 Aug 27 Sep 12 Sep 28 Oct 14 Oct 30 Nov 15 Dec 01 Dec 17 GBP/ZAR USD/ZAR in GBP average vs Dec 19 Average Dec 20 Average Jun 20 Average Dec 19 vs Jun 20 closing GBP vs Jun 20 closing USD Spot vs Average real rates: 20-year point 0% 1% 2% 3% 4% 5% 6% Jan-15 May-15 Sep-15 Jan-16 May-16 Sep-16 Jan-17 May-17 Sep-17 Jan-18 May-18 Sep-18 Jan-19 May-19 Sep-19 Jan-20 May-20 Sep-20 Jan-21 May-21 PIT Spot Rates Avg Spot Rates Spot rate Average rate -- 15 of 85 -- 16 Reported profit for period affected by currency and interest rates Rm 6 months ended Dec 2020 6 months ended Dec 2019 % Normalised profit from operations before economic assumptions adjustments 4,507 3,792 19% Economic assumptions adjustment DL* (493) - Economic assumptions adjustment VL* 1 (230) Normalised profit from operations after economic assumptions adjustments 4,015 3,562 13% Finance charges excl. 1DP finance lease -649 -581 Forex and remeasurement of currency derivatives -569 33 Deferral fees related to Prudential Book transfer -96 0 Investment income and fair value remeasurements 149 196 Other -231 -235 Profit before tax 2,619 2,975 -12% Tax (744) (897) Profit attributable to preference shareholders (34) (41) Profit attributable to equity holders 1,841 2,037 -10% Other 1 10 Headline earnings 1,842 2,047 -10% Economic assumptions adjustment (DL and VL)* 354 186 Remeasurement of currency derivatives 149 8 Other -61 71 Normalised headline earnings 2,284 2,312 -1% *Net of discretionary margins and net of gains/(losses) on derivatives to offset such changes in economic assumptions +19% -10% -1% Recon Dec 20 vs Dec 19 growth Normalised operating profit Finance charges Forex and currency Economic assumptions (normalised) Tax and other Headline earnings Normalisation adjustment Normalised headline earnings +1% -19% -9% -3% +9% derivatives remeasurements Currency Interest rates Interest rates -- 16 of 85 -- Operating model performing well and driving growth, with strength in capital and liquidity 2 -- 17 of 85 -- 18 Group operating model Cash generated Cash used Tax New business Funding Cash spent Finance costs and dividends New businesses <50% per business Operating cashflow Net cashflow Growth Engine Cash Management Capital Model SA Liquidity R1-2bn FLR < 28% Capital Regulatory capital and reserves Allocated capital for planned initiatives Allocated debt Allocated debt is part of the funding strategy Additional buffer Buffer for volatility and unknown investments 1 in 25 year event ~5 years ~5 years ESTABLISHED EMERGING NEW Normalised Operating Profit ROC RF + 10% Group profit growth -- 18 of 85 -- 19 Strong growth from Emerging and slowing investment in New 1 670 +6% 1 922 +3% 471 -3% 613 +24% 327 +206% Established 5 003 +10% 107 +43% 238 +116% 112 +65% Emerging 457 +81% New (999) +0% Rm Operating profit R4.5bn Health insurance Life insurance ESTABLISHED BUSINESSES EMERGING BUSINESS NEW Established excludes SA Vitality, including SA Vitality Established is R5 049m -250 0 250 500 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 0 400 800 1,200 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 +81% +50% +71% -0% +81% +113% +65% -- 19 of 85 -- 20 3 167 -5% 1 162 -6% 1 316 -3% 638 +4% 561 -13% Established 6 844 -5% 617 +12% 625 +21% 1 805 +31% Emerging 3 047 +24% New 1 005 +169% Rm New business R10.9bn Health insurance Life insurance ESTABLISHED BUSINESSES EMERGING BUSINESS NEW - 1,000 2,000 3,000 4,000 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 32% 5 yr CAGR 171% 2 yr CAGR - 400 800 1,200 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 1 Established excludes SA Vitality, including SA Vitality Established is R6 868m 1 Including new closed schemes +24% +20% +55% +30% +169% +173% Emerging and New contributed to strong total new business API -- 20 of 85 -- 21 Despite small earnings contribution from Emerging and New, they contribute significantly to revenue and membership growth - 2,000 4,000 6,000 8,000 10,000 12,000 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Total new business API “Revenue” “Revenue” share "Gross inflows + Bank revenue + 25% PAH GWP" Total new business API share 63% 28% 9% 84% 16% 87% 13% 73% 26% 1% H1 2018 H1 2021 - 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 H1 2018 H1 2019 H1 2020 H1 2021 -- 21 of 85 -- 22 Emerging businesses are scaling and creating value H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Operating profit Operating profit Operating profit ROE ROE ROE -114 99 169 253 457 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Strong growth from Emerging 13.5%ROE Operating profit Rm ROEs for the six months to December 2020, annualised -- 22 of 85 -- 23 New market launches over next 18 months New businesses continue to see considerable traction VitalityInvest DBI Umbrella Funds +77% to R124m +247% to R592m R6.1bn J A S O N D J F M A M J J A S O N D J Retail deposits GBP millions +95% to £151.2m New business New business J S N J M M J S N J M M J S N J A O D F A J A O D F A J A O D New business APE J S N J M M J S N J M M J S N Bank Vitality1 2020 2021 2019 2019 2020 2018 2019 2020 2018 2019 2020 2018 5% 7% 15% 26% 22% H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 % in New decreasing Cumulative new business Cumulative new business Cumulative new business BRAZIL MEXICO ISRAEL CZECH REPUBLIC SPAIN ITALY POLAND VIETNAM 61% 15% 8% 16% Bank VG VI Other Majority in Bank 53% 9% 16% 22% H1 2020 H1 2021 +123% ZAR -- 23 of 85 -- 24 Cash generated Cash used Funding New business Net cash flow1 New businesses Net cash generated from in-force business R5.8bn Tax and finance costs R1.5bn R3.9bn R0.4bn R0.9bn Cash management supports the growth methodology Cash generated from in-force 1 Movement in shareholder free cash Cash used net of funding Net cash flow Reinsurers Debt R0.9bn -- 24 of 85 -- 25 Group is well capitalised and highly liquid 15% 17% 19% 21% 23% 25% 27% 29% Rm Dec 19 Cover Dec 20 Cover 1.7x 1.8x 1.7x 1.8x 1.4x 2.0x 1.7x 2.0x 2.2x 1.3x 28% DHMS solvency (unaudited) 36.8% 1 Capital Adequacy Ratio 2 Considers SA Liquidity and liquid excess assets for Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank 3 SA cash + undrawn committed facilities 1 SA Liquidity3 , R millions FLR R millions Liquid excess assets above regulatory capital requirements Strongly capitalised FLR is within target Highly liquid across the Group2 Sufficient liquidity at the centre - 200 400 600 800 1,000 1,200 1,400 1,600 1,800 2,000 FY18 FY19 FY20 H121 - 2,000 4,000 6,000 8,000 10,000 12,000 14,000 FY18 FY19 FY20 H121 -- 25 of 85 -- 26 Positive non-economic experience variances Annualised ROEV, 11.7% excluding forex and economic changes Group Embedded Value Health Life and Invest VH VL Total Lapses* -36 375 67 193 599 Renewal expenses 102 13 80 25 220 Mortality and morbidity - 62 92 12 166 Other 261 113 89 -142 321 Total 327 563 328 88 1 306 Opening EV Value of new business Unwind of RDR Non-economic experience variances Non-economic methodology & assumption changes Operational EV Economic experience Forex EV before below the line items Group initiatives Other Change in capital and dividends Closing EV Operational EV Economic impact Initiatives and other R72 467m R73 424m R75 992m R70 834m & assumption changes *Lapses, surrenders and policy alts -- 26 of 85 -- A pivot to growth following trends emerging through COVID-19 3 -- 27 of 85 -- 28 Shared-Value dynamics manifest across all industries LIFE HEALTH MOTOR LONG-TERM SAVINGS Claims Lapses SA UK Market A Blue Bronze Silver Gold SA UK Blue Bronze Silver Gold SA UK Blue Bronze Silver Gold Blue Bronze Silver Gold BANK TECHNOLOGY AND ANALYTICS LAYER DATA LAYER BEHAVIORAL LAYER INCENTIVE LAYER PRICING LAYER VITALITY MONEY POINTS VITALITY MONEY STATUS DEBT MANAGER SPEND MANAGER ACTIVE REWARDS DEFAULTS Dynamic interest rates Dynamic discounts MONEY PRODUCTS TRANSACTIO N CREDIT VISA SAVINGS DYNAMIC INTEREST RATES DISCO VERY MILES DYNAMIC DISCOUNTS Spend Arrears -- 28 of 85 -- 29 The three trends have been accelerated by COVID-19 The rise of digital Ways of work Ecommerce Telemedicine Contactless ESG Moral money Climate change Social movements Mortality Morbidity Driving Investing Banking Purpose and ESG Focus on wellness and resilience Growth of digital platforms Importance of healthcare Health first Healthcare ecosystems Preventative services Distribution models Servicing models Green agenda Empowered customers -- 29 of 85 -- 30 Importance of physical activity on health and risk Causal impact of changing physical activity levels Impact on hospitalisation Impact on mortality Adjusted and standardised healthcare claims by days of qualifying physical activity Mortality by disease type by physical activity Changing measurements to more sophisticated health measures Extending beyond activity to Cardio Respiratory Fitness (CRF) Mortality relativities by CRF levels [-367,-5) [-5,5) [5,75) [75,366) Increase in PA days per year Decrease in PA days per year 18% Bayes Network model 18% lower risk of being a high-cost claimer 1000 1100 1200 1300 1400 1500 0 50 100 150 200 250 300 350 Physical activity days per year Unknown CRF Poor CRF Average CRF Good CRF No Vitality Blue Bronze to Diamond Ischaemic heart disease Cerebrovascular heart disease Hypertensive heart disease Infectious and parasitic diseases Injuries Unintentional Injuries Respiratory diseases Diabetes mellitus Digestive diseases Neurological conditions Respiratory infections Unengaged No Vitality Engaged -- 30 of 85 -- 31 1.0 0.7 0.6 2.6 1.7 1.5 3.0 1.7 1.3 9.0 5.8 4.8 Low Med High Low Med High Low Med High Low Med High Understanding resilience Impact of health and lifestyle on COVID-19 related risk COVID-19 mortality by Vitality status COVID-19 mortality risk by level of physical activity engagement Life COVID-19 mortality rate by Vitality status 40-49, no chronic conditions 40-49, hypertension and diabetes 60+ no chronic conditions 1 Engagement in Vitality can offset the elevated COVID-19 risk associated with aging 2 Engagement in Vitality can offset the elevated COVID-19 risk associated with lifestyle chronic conditions Only clients with at least one comorbidity Only clients over age 60 -71% Vitality engagement reduces mortality risk regardless of age or comorbidities -74% -81% 60+ hypertension and diabetes -- 31 of 85 -- 32 Building and curating a wellbeing ecosystem Institution C O N S U M E R ATTRACT UW AND PRICE CHANGE BEHAVIOUR RETAIN L I N E S O F B U S I N E S S C O N S U M E R S Building capability to translate behaviour to the different lines of business Personal pathways Access to curated programmes Supported by device, strategic and reward partners B E H A V I O U R A L C H A N G E & E N G A G E M E N T G A T E W A Y P A R T N E R S T E C H N O L O G Y A N D A N A L Y T I C S L A Y E R MEDITATION SLEEP NUTRITION WEIGHT Calm Headspace Pzizz Sleep cycle MyFitnessPal LoseIt Lark Shapa Withings Breathe Institution DEVICE STRATEGIC REWARD Collaborative model assisting customers to manage their health by combining data, incentives, personalisation and providers GATEWAY CONNECT GATEWAY GUIDE GATEWAY EXCHANGE -- 32 of 85 -- 33 Discovery Health’s platform -- 33 of 85 -- 34 Comprehensive Digital Health Ecosystem – all in production, fully integrated into products and the administration/claims platform INTEGRATED HEALTH AND WELLNESS APP WELLNESS DEVICE INTEGRATION VIRTUAL CONSULT PLATFORM ONSITE WELLNESS SERVICES HOMECARE SERVICES CARE CO- ORDINATED SERVICES FUNDER HEALTHID INTEGRATED ELECTRONIC HEALTH RECORD AND INTERACTION PLATFORM DOCTOR CONNECT VIRTUAL CONSULT PLATFORM WITH DEVICE INTEGRATION DIAGNOSE FULL PATIENT RECORD INCLUDING MEDICATION, PATHOLOGY AND RADIOLOGY WELLNESS AND PREVENTION PRESCRIBE PERSONAL DISEASE MANAGEMENT PATHWAYS VITALITY ACTIVE REWARDS FOR DOCTORS CARE AND TREATMENT VIRTUAL CONSULTATIONS VALUE BASED CARE PROGRAMS PRODUCT SUITE INTEGRATED CLAIMS AND ADMINISTRATION PLATFORM PATIENT MANAGEMENT PLATFORMS COACHING PLATFORM DISEASE PREDICTION MODELS VALUE BASED CARE PROGRAMS MANAGEMENT CARE PROGRAMS COACHES AND CARE MANAGERS ASSETS KNOW YOUR HEALTH PERSONAL HEALTH RECORD HEALTH INFORMATION LIBRARY AI SYMPTOM CHECKER SCREENING WELLNESS AND PREVENTION AR2020 + GATEWAY VITALITY 65+ NUTRITION ASSESSMENT AND COACHING FITNESS ASSESSMENT AND COACHING CARE AND TREATMENT VIRTUAL CONSULTS WITH DEVICES SECOND OPINION PERSONALISED DISEASE MANAGEMENT MEDICINE ADHERENCE CARE COORDINATION HOMECARE SERVICES ASSETS ASSETS PATIENT DOCTOR -- 34 of 85 -- 35 Growth of digital platforms -- 35 of 85 -- 36 Addressing social issues through the Shared-Value model INSURED SOCIETY INSURER Better health, incentives and a lower cost of insurance Fewer deaths Fewer illnesses Lower claims Lower lapses Healthier society Improved productivity Reduced healthcare burden Make people healthier CORE PURPOSE “It is not a problem” “It is a problem” “Let’s solve the problem” “It’s an opportunity“ “Let’s define a purpose“ Donations to worthy social causes Volunteering Mitigating risk and harm Improving trust and reputation Achieving ESG standards and Global Reporting Initiative measures Answering “why do we exist?” as a company Addressing societal needs and challenges through the business itself, with a business model -- 36 of 85 -- 37 Discovery’s climate strategy and impact Discovery’s emission profile Comparison to JSE Large Cap A B C D E F G H I J K L M N O P Q R S T DSY JSE Large Cap Companies Average (26.3m Tons) SHORT TO MEDIUM TERM Achieve carbon neutrality in our SA, UK, and US operations by 2025 (Scope 1 and 2 emissions) 55 548 Tons CO2e per year (2019) Audited by -- 37 of 85 -- 38 Shared-Valued model conceptually applicable for green behaviour change controllable behaviours of personal household emissions Electricity Nutrition Driving Flying -- 38 of 85 -- The businesses well positioned in the four strategic strands 4 -- 39 of 85 -- 40 The businesses in the four strategic strands SA COMPOSITE MODEL UK COMPOSITE MODEL PARTNER COMPOSITE MODEL Health Life Invest Perfect composite model, #1 in every industry, and laboratory for shared value in financial services. A successful entry into banking The best insurer in the UK, making use of a composite Shared-Value Model Vitality is the world’s largest and most sophisticated behavioural platform linked to financial services, with disciplined execution Ping An Health delivers on its plan to become the leading health insurer in China with over 50m clients -- 40 of 85 -- 41 Health Life Invest SA COMPOSITE MODEL -- 41 of 85 -- 42 Clients Retail deposits Advances Accounts J A S O N D J F M A M J J A S O N D J F J A S O N D J F M A M J J A S O N D J F 2020 2021 2019 2020 2021 2019 J A S O N D J F M A M J J A S O N D J F 2020 2021 2019 300k S O N D J F M A M J J A S O N D J F 2019 2020 2021 As at 24 February 2021 Post-BIN migration Post-BIN migration Post-BIN migration Post-BIN migration -- 42 of 85 -- 43 Full suite and differentiated proposition results in diversified income streams Savings only DTA (PAYT) DTA (Bundled fee) Credit card Suite BIN migrated New clients and accounts continue to grow steadily with efforts focused on new-to-Bank clients following the migration NII NIR 59% 41% Revenue components Product mix New accounts and average daily new-to-Bank sales Accounts Average daily sales >556k S O N D J F M A M J J A S O N D J <70 >350 A M J J A S O N D J -- 43 of 85 -- 44 5% 95% Top 10 deposits as a % of total Other as a % of total Retail deposits Deposits have grown strongly, in line with the strategy to build a retail deposits-led bank Deposits are sticky and diverse By Vitality Money status Retail deposits tenure Concentration risk 44% 56% > 3 months < 3 months 1% 4% 9% 1% 51% 34% Blue Bronze Silver Gold Diamond None International comparison Discovery Bank deposit growth is best in class after 14 months of operation Deposits per customer (R ‘000) 19.8 1.2 7.4 6.3 Discovery Bank Tyme Bank Monzo Revolut J A S O N D J F M A M J J A S O N D J F 2020 2021 2019 97% growth post-migration -- 44 of 85 -- 45 Advances Credit quality Market share Advances remained flat reflecting the decrease in consumer spending and prudent lending approach 0 100 200 300 400 500 600 700 800 Client credit score Exceptionally low risk Low risk Medium risk High risk Very high risk of clients have their largest credit card balances with Discovery Bank 0% 10% 20% 30% 40% 50% 60% 1 2 3 4 5+ % of population DSY balance rank Discovery Bank balance rank J A S O N D J F M A M J J A S O N D J F 2020 2021 2019 Post-BIN migration -- 45 of 85 -- 46 Increasing engagement VM status agnostic to income levels, correlations aligned to pricing basis Shared-Value fundamentals Increasing client engagement and Shared-Value fundamentals emerging as expected Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Base Miles Fuel HealthyLiving Iphone Active rewards Miles Vitality Money take-up Increase in rewards engagement since Jul-20 lower arrears rate higher deposit levels greater spend Blue Bronze Silver Gold Diamond Vitality Money status Savings only Account type 31% 45% 16% 5% 4% Gold 43% 33% 15% 5% 3% Platinum 27% 36% 22% 9% 6% Black 20% 34% 25% 13% 9% Purple 10% 25% 24% 14% 27% Percentage of consumers in arrears by Vitality Money status Deposits by Vitality Money status Spend by Vitality Money status Three months average 4.4% 0.9% 0.3% 0.2% 0.0% Blue Bronze Silver Gold Diamond 7,443 8,345 20,200 27,352 131,881 Blue Bronze Silver Gold Diamond 8,093 12,557 19,572 21,147 58,892 Blue Bronze Silver Gold Diamond -- 46 of 85 -- 47 Value drivers are trending in the right direction and the Bank is well- positioned for growth Client growth Deposits Product mix Advances Value drivers Strategic focus areas Expanding distribution channels and leads sources Accelerated issue resolution Enhanced onboarding Streamlined credit application process Zoom co-browsing Thought leadership and brand awareness Large and highly productive tied adviser base Targeting of engaged Vitality clients Real-time upselling Pre-scoring Vitality members for credit Numerous features and propositions in the pipeline -- 47 of 85 -- 48 Operating profit Rm Lapses Membership New business* Rm to R1 670m lives under administration 5.57% 5.19% Dec-19 Dec-20 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 Non-scheme products Closed schemes DHMS H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 to R3 167m *New business excl. new closed schemes: -17% to R2 788m improvement -- 48 of 85 -- 49 Medical scheme growth impacted by the contraction in employment DHMS growth Closed scheme growth Retail product growth lives closed schemes Jan-18 Apr-18 Jul-18 Oct-18 Jan-19 Apr-19 Jul-19 Oct-19 Jan-20 Apr-20 Jul-20 Oct-20 Primary Care Gap cover Healthy Company 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 lives LIBERTY MEDICAL SCHEME Type I Type II H1 2020 H1 2021 DHMS new business API by business type year-on-year revenue growth Net gain of lives in Jan-21 : new employer groups Type II: new employees on existing groups -- 49 of 85 -- 50 Membership and growth Lapses and stability Security and surplus 1 Council of Medical Schemes unaudited solvency credit rating Plan movements stability Downgrade No movement Upgrade lives market share1 as at Sep 2020 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 2.2% 1.6% 96.2% 2020 plan movements Debit order rejections 2002 2004 2006 2008 2010 2012 2014 2016 2018 2020 Increased by 3% 4% 5% 6% 7% Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 -- 50 of 85 -- 51 Solvency build-up driven by the decline in non-COVID-19 healthcare utilisation 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Surplus build-up emerging due to COVID-19 R27.5bn R19.2bn Impact on utilisation Weekday OH claims index (rolling 3-day average) Weekday hospital admissions index (rolling 3-day average) Private hospitals Day clinics Psychiatric hospitals Radiologists Paediatricians GPs Claim cost change by service month Claim cost change by service month 14.6% -79.6% 4.2% 38.7% 6.9% Jan… Mar May Jul Sep Nov Jan… 22.7% -48.0% -30.5% -6.5% Jan… Mar May Jul Sep Nov Jan… 8.9% -44.9% -10.1% 3.0% Jan… Mar May Jul Sep Nov Jan… 2020 2021 2020 2021 2020 2021 3.4% -10.2% -39.5% -32.2% 3.7% -13.1% Jan… Mar May Jul Sep Nov Jan… 7.9% -40.2% -21.8% -30.8% -19.3% 1.9% Jan… Mar May Jul Sep Nov Jan… 8.1% -49.0% -30.9% 8.2% -22.6% Jan… Mar May Jul Sep Nov Jan… 2020 2021 2020 2021 2020 2021 DHMS solvency results projected with IBNR, unaudited -- 51 of 85 -- 52 New business Normalised operating profit to R1 162m to R1 922m Exceptionally strong operating variances Positive non-economic variances Includes Discovery Invest H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Impact of c.R1.8bn capital release at June 20 Impact of c.R166m in Group Life claims not covered by COVID-19 provision 224 Lapses and surrenders Policy alterations Mortality and morbidity Premium and fee income Other Total H1 2020 H1 2021 563 Lapses and surrenders Policy alterations Mortality and morbidity Premium and fee income Other Total -- 52 of 85 -- 53 Positive operational experience variances, driven by exceptionally strong persistency 81.0% 90.2% Count EV H1 2020 H1 2021 Resilient value of new business and increase in embedded value Strong lapse experience and improvement in non COVID-19 claims experience 100% Lapse experience AvE 105.9% 99.6% H1 2020 H1 2021 EV variance Claims experience AvE (excl identified COVID-19 claims) 408 291 H1 2020 H1 2021 9.5% 5.9% 8.2% H1 2020 FY 2020 H1 2021 VNB (Rm) Life: Annualised VNB margin (%) Life: Jun-20 Dec-20 Embedded value: Life and Invest R31.8bn R33.8bn Driven by: • Tight expense controls • Improved business mix • Economic assumption changes Margin improved vs. June 20 -- 53 of 85 -- 54 Dec-19 Jun-20 Dec-20 Adjusted for claims up to mid-February Robust position evident in strong cashflow, capital coverage and liquidity Strong cash emergence over the period Life and Invest R millions Maintained strong capital position High levels of liquidity coverage 182% 182% 172% Dec-20 Jun-20 Dec-19 125% SCR target R4.1bn Assets available to meet liquidity needs R2.8bn R4.1bn Premiums and Fees Net Claims Operational costs Cashflows from existing NB Strain Cashflow before FinRe Net FinRe Life&Invest Net cashflow 7 605 2 050 653 231 cR560m of COVID-19 claims paid within the period, largely offset by FinRe recovery NB and servicing strain -- 54 of 85 -- 55 COVID-19 claims experience peaked in January 2021, and has run down materially as at mid-February Significant provision utilisation during the January peak, has abated during February Total provisions in excess R1bn remain even after allowing for Jan and Feb claims Amplified relevance of shared-value life insurance through the pandemic 31-Dec-20 7-Jan-21 14-Jan-21 21-Jan-21 28-Jan-21 4-Feb-21 11-Feb 18-Feb Weekly progression Increase in claims provision utilisation over 4 weeks Total Claims Paid R393m R987m R418m R532m R652m R807m R1 044mR1 070m 594 83 31-Dec-20 January Claims 1st-18th February claims Total Provision at mid-February R1 741m R1 064m Feb-19 Jun-19 Oct-19 Feb-20 Jun-20 Oct-20 Lowest since inception Lapse rate Death claims (actual vs expected) Counter to higher claims through this period has been significantly lower lapse experience 31-Mar 14-Apr 28-Apr 12-May 26-May 9-Jun 23-Jun 7-Jul 21-Jul 4-Aug 18-Aug 1-Sep 15-Sep 29-Sep 13-Oct 27-Oct 10-Nov 24-Nov 8-Dec 22-Dec 5-Jan 19-Jan 2-Feb 16-Feb Exposed Life benefits (R'm) on 127 lives on 386 lives Death claims in the 1st and 2nd waves Feb-19 Jun-19 Oct-19 Feb-20 Jun-20 Oct-20 Highest since inception Clients have recognised the value of keeping their cover in place -- 55 of 85 -- 56 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 to R1 316m New business Rm Assets under administration Normalised operating profit Rm 20 16 20 17 20 18 20 19 20 20 to R107bn 2016 2017 2018 2019 2020 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 to R471m Rbn -- 56 of 85 -- 57 Efficacy of Shared-Value model works locally and is moving abroad Discovery Invest platform Shared-Value model produces exemplary outcomes Discovery Internal data 31 December 2020. Flows data from ASISA as at 31 December 2020. Performance data as per Morningstar 31 December 2020 Actual v expected Proposition has created the fastest growing retail investment provider Dec-07 Sep-08 Jun-09 Mar-10 Dec-10 Sep-11 Jun-12 Mar-13 Dec-13 Sep-14 Jun-15 Mar-16 Dec-16 Sep-17 Jun-18 Mar-19 Dec-19 Sep-20 Asset growth (rebased to 100 as at 31 Dec 2007) AUM Growth since December 2007 Discovery Competitor A Competitor B Competitor C Competitor D Competitor E Competitor F Competitor G Competitor H Competitor I Competitor J Competitor K Competitor L Competitor M Actuarial dynamics Vote of confidence during COVID Withdrawals Paid-ups Digital technology and quality servicing Data Incentives Behaviour invested in preferred funds lower lapse rates more ad-hoc contributions lower drawdowns Actual v expected -- 57 of 85 -- 58 to 6%* to R107m (excl. Commercial) to R2 121m* H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 to R617m* H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 New business Market share in GWP Operating margin Gross written premium H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 *Personal Lines only. Assumes 6% in GWP market growth since 2018 *Personal Lines only Normalised operating profit -- 58 of 85 -- 59 16% 8% 5% 4% 2% -7% Increased margin a direct result of the economics of the model Year 1 Year 2 Year 3 Year 4+ Gold Blue Bronze Silver Year 1 Year 2 Year 3 Year 4+ Public buy-in Source: NAAMSA; Property24 2020 Growth in GWP -3 -1 3 4 6 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Margin (%) Shared-Value model drives the economics Resultant margin Lapse rates Gold Blue Bronze Silver Loss ratios By Vitality status By duration inforce Lapse rates Loss ratios Despite a decline in home transfers and new vehicle sales in 2020, DSY Insure new business sales stayed strong at -- 59 of 85 -- 60 Data provides fascinating advantage in insights and application Blue Bronze Silver Gold Volkswagen Toyota Ford Mercedes-Benz BMW Hyundai Audi Blue Bronze Silver Gold Female Male Blue Bronze Silver Gold 18-30 31-50 51-65 65+ Blue Bronze Silver Gold Gauteng Western Cape Kwazulu-Natal Eastern Cape Other Vitality drive status differentiates risk within traditional pricing factors Frequency of claims by Vitality Drive Status Age Province Gender Automobile Actual DSY Experience Discovery Pricing Non-Telematics Pricing Blue Bronze Silver Gold Competitors underpricing and making losses Competitors overpricing; DSY rewarding clients for better risks Understanding behaviour provides superior accuracy over traditional pricing -- 60 of 85 -- 61 Model and data enables emphasis on the customer and is replicable Vitality Drive 2.0 Vitality Drive 65+ Discovery Insure vehicle warranty kilometres tracked claims paid cashback paid Discovery Insure’s personal lines platform Platform enables capabilities and new manifestations insured assets International expansion claims processed rewards earned -- 61 of 85 -- 62 Health Life Invest UK COMPOSITE MODEL -- 62 of 85 -- 63 New business Earned premiums Normalised operating profit Lives covered to 1.3m lives GBP millions to £409.4m* to £56.4m GBP millions H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 to £44.2m GBP millions H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Health and Life insurance *Excludes UPR adjustment Excludes Vitality at Work (formerly Healthy Workplace and Essentials) -- 63 of 85 -- 64 Service recognition The composite is working well and receiving recognition Vitality engagement: deep and correlated UKCXA’20 UK Customer Experience Awards Celebrating women in sport Brand well established Simplified customer journeys Neoplasms Musculoskeletal Cardiovascular Respiratory Bronze Silver Gold Platinum Relative IH claims experience Relative lapse experience Source: Mortality: Vitality impact on mortality (using causal inference), 2016-2020 Morbidity: Vitality Continuous Mortality, Lapse and Engagement (CMLE) investigation, 2017. Standardised for Age, Gender, SE Class, Initial RUB; Rebased to Bronze status Retention: 12-mth Rolling Average Actual VS Expected Lapse Rates for Optimised policies by Vitality Status Leading companies evaluated: Overall Winner Workplace Wellbeing Team Relative mortality rates Bronze unengaged Bronze engaged Silver Gold Platinum 14 19 25 29 30 37 50 50 51 53 H2 2014 H1 2017 H1 2019 H1 2020 H2 2015 No measure H2 2020 COVID-19 Prompted brand awareness -- 64 of 85 -- 65 Shared-Value Insurance Model is consistent across the Group LIFE OPTIMISER ABC RENEWAL PRICING HEALTHY FEE SAVER STATUS-LINKED EXCESS Healthier ageing and improved financial wellbeing Improved driving, both safer and greener Improved morbidity and mortality Improved morbidity Up to 0% asset management fees Reduce excess by up to £250 and eliminate increase Up to 30% upfront discount Reduce increase through health engagement -- 65 of 85 -- 66 New business Lives covered Normalised operating profit to 693k lives* Earned premiums GBP millions to £256.5m* to £30.0m GBP millions H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 to £28.8m GBP millions H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Health insurance *Excludes UPR adjustment *Excludes Vitality at Work (formerly Healthy Workplace and Essentials) -- 66 of 85 -- 67 The quality of the book is strong H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Exceptional retention Lapse rates Strong cash generation after allowing for UPR adjustment GBP millions, after allowing for COVID-19 provisions 0 10 20 30 40 50 60 70 H1 2018 H1 2019 H1 2020 H1 2021 0 10 20 30 H1 2018 H1 2019 H1 2020 H1 2021 Inforce book cash generation Net cash generated £46m £47m £51m £59m £22m £20m £23m £25m -- 67 of 85 -- 68 UPR adjusted for treatments delayed due to COVID-19, and roughly equal to 2 months of claims 0% 20% 40% 60% 80% 100% 120% Cardiac Musculoskeletal Oncology Psychiatry Overall Monthly authorisations per 1 000 lives Pre COVID-19 Still below expectation due to second wave, but expect catch-up on delayed treatments Authorisations still below pre-COVID-19 levels Claims spend expected compared to authorisations received 0% 20% 40% 60% 80% 100% 120% 140% Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Jan-21 Feb-21 Mar-21 Apr-21 May-21 Jun-21 %age of normal claims spend expected in business plan UPR provision roughly 2 months of claims Wave 1 Wave 2 -- 68 of 85 -- 69 to 648k lives New business Lives covered Normalised operating profit Earned premiums to £152.9m GBP millions to £26.4m GBP millions H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 to £15.4m GBP millions H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Life insurance -- 69 of 85 -- 70 COVID-19 impacted the overall market with a reduction in total sales Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q2 2020 Q3 2020 -22% -23% Source: Touchstone, Oct 2020 COVID-19 impact to £26.4m GBP millions H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 VitalityLife new business UK IFA market new business -- 70 of 85 -- 71 Vitality Life benefitting from the restructure 0% 20% 40% 60% 80% 100% 120% H1 2016 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Steps taken to address retention Unfavourable variances remedied from July 2020 Lapse AvE at all-time low AvE lapses Expected IFRS reserve variance -4 -3 -2 -1 0 1 2 3 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Millions -- 71 of 85 -- 72 H1 20 before experience variances H1 20 actual before interest and hedge impact Interest and hedge impact H1 20 operating loss H1 20 restated operating profit Profits are reverting, as expected £9m -£7m £15m Reduction due to experience variances -£16m H1 2020 normalised operating profit recon H1 2021 operating profit recon H1 21 expected Experience variances Strengthening of provisions Interest and hedge impact H1 2021 operating profit £15.4m £15m £7.6m Lapses +£9.4m -£8.9m £5.8m -- 72 of 85 -- 73 Health Life Invest PARTNER COMPOSITE MODEL -- 73 of 85 -- 74 New business1 Written premium1 PAH’s operating results pre-tax Discovery’s operating result after tax to R7.2bn to R18.1bn to R1bn (DSY’s share is R253m) to R112m 1 100% of PAH H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 -- 74 of 85 -- 75 - 1 2 3 4 5 6 7 8 2017 2018 2019 2020 Billions Exceptional new business growth in the 1st half of PAH’s financial year Six-monthly new business RMB Although new business slowed in the latter half, it achieved its full-year revenue target 2020 2019 2018 2017 0 1 2 3 4 5 Jan-Jun Jul-Dec Jan-Jun Jul-Dec Jan-Jun Jul-Dec Jan-Jun Jul-Dec Billions +26% Calendar year new business RMB +35% +105% -- 75 of 85 -- 76 PAH continues to focus on growth and broadening its sales channels Continued expansion of offline distribution footprint Transformed distribution strategy to capture different parts of market Agents Business Customer Government 2A 2B 2C 2G Deepen collaboration with Ping An Group subsidiaries Partner with major third- party platforms SuiShenYi platform Group business through large established brokers & PAH’s own direct sales team Micro top-up medical reimbursements products Building digital distribution strategy for agents Commission My Sales Status My Sales tracker Pending payment Completed Expired 3 days ago SuiShenYi platform Online platform where anyone can register to be an agent to sell PAH insurance products Henan Jiangsu Shanghai Zhejiang Guangdong Hubei Chongqing Sichuan Beijing Liaoning Tianjin Shenzhen Tier 2 branches: Beijing, Shanghai, Guangdong, Shenzhen, Jiangsu, Zhejiang, Liaoning, Tianjin, Sichuan, Suzhou, Hebei, Chongqing, Henan, Hubei Hubei added Nov 2020 -- 76 of 85 -- 77 Ping An Group continues to invest in its extensive healthcare ecosystem Government Patients Provider Technology Payer PA Good Doctor 903K daily consultations Online Offline PA Good Doctor Health commissions Ping An Life Ping An Annuity HealthKonnect Ping An Health Research Institution Investment Institution Healthcare Technology Research Institute Toda Bio-research Voyager Global Fund Ping An Ventures Overseas Holdings PAH benefits from this Group investment through products, networks and channels The ecosystem brings together users with online and offline providers of products and services The ecosystem is served by a single digital platform Medical products administration Healthcare security administration Implemented in 158 cities across 30 provinces Ranked 1st globally by digital healthcare applications Invested in nearly 100 companies in the healthcare industry 373m registered users PA Good Doctor PA Good Doctor 21K institutions Institutions Doctors Pharmacies 1000+ partner hospitals across world 650K doctors served 21K+ external contracted doctors 150K+ partner pharmacies Digital platform strategy with integration of various offline players -- 77 of 85 -- 78 PAH app being merged into Good Doctor app, which is to become the digital platform serving the Ping An Group healthcare ecosystem Mission: provide full range of health management services covering prevention, treatment and rehabilitation Important flagship of Ping An’s healthcare ecosystem bringing users into an ecosystem of product and service providers New app is called Ping An Health Vision: bring health to all Chinese and promote the construction of Healthy China, promoting the transition from disease treatment-centric to health-centric Ping An Good Doctor: China’s leading online healthcare services platform Registered users Average daily consultations Monthly active users in millions as at Sep 2020 67 5 Ping An Good Dr We- Doctor Ali Health JD Health Jianke ChunYu YiSheng Hao Dr DXY Zhi Yuan Wei Mai -- 78 of 85 -- 79 Health Life Invest PARTNER COMPOSITE MODEL -- 79 of 85 -- 80 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Integrated new API by insurance partners Revenue Operating result Insurance and franchise partners membership All numbers exclude new VG initiatives, i.e. myOwn and Vitality1 *From insurance partners H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 Vitality USA Insurance Partners H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 R8.7bn R625m 2.1m H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 USD537m USD38m USD14.6m R238m (+116% ZAR) (+21% ZAR) (+0.3% ZAR) -- 80 of 85 -- 81 Integrated new API by insurance partners All numbers exclude new VG initiatives, i.e. myOwn and Vitality1 *From insurance partners H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 R8.7bn USD537m (+0.3% ZAR) In-market growth continued, despite challenging environment *AIA and Sumitomo figures are for 2020 calendar year. John Hancock and Generali relative figures are over FY2021H1. Vitality’s health and wellness message resonated with buyers and helped our partners build resilient businesses during COVID-19 Vitality integrated Non-integrated J A P A N U S A A L L M A R K E T S Sales growth 2020 v 2019 (pp difference rebased to non -integrated) G E R M A N Y Member growth Relative to 2020H1 -- 81 of 85 -- 82 Vitality engagement remained strong across our markets 0% 25% 50% 75% 100% 125% 150% 175% 1-Sep-19 1-Dec-19 1-Mar-20 1-Jun-20 1-Sep-20 1-Dec-20 Relative engagement COVID Resilient Vitality engagement during COVID-19 Markets experienced a moderate decline in Q1 with global uncertainty and lockdowns taking effect 2020 Q3 and Q4 showed the effect of various market interventions implemented and easing of lock-down measures Vitality enabled partners to respond and drive engagement with clients during COVID-19 2019 2020 2019 2020 Total workouts At home workouts Avg per person 2020Q2 2020Q3 Physically active Engaged v Unengaged % of members Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Goal completion Equivida Saludsa Active Rewards goal achievement rate Ecuador’s largest virtual gym Vitality Run&Walk Challenge Mobilised a powerful COVID-19 response, with Vitality at its core COVID-19 DATA ANALYSIS INCENTIVES FOR VACCINATION PROMOTIONS AND GUIDANCE SOCIAL STRATEGY PLAYBOOK COMMUNICATION TOOLS SUPPORT -- 82 of 85 -- 83 Vitality localised and tailored to market needs Vitality spans multiple markets, regulators, languages, time zones, vendors, rewards partners, currencies and types of financial services Prudential Argentina ASR Netherlands IGI Life Pakistan Fidelidade Portugal SaludSA Ecuador Tawuniya Saudi Arabia National champions John Hancock USA Manulife Canada Generali Germany AIA South Korea AIA Singapore AIA Australia AIA Indonesia AIA Philippines AIA Hong Kong AIA Thailand Franchise markets VG USA Employee wellness Aetna Attain USA Powered by Generali Austria Generali France Manulife is a trademark of The Manufacturers Life Insurance Company and are used by it, and by The Discovery Group under license -- 83 of 85 -- 84 +8% including DH take-on of new closed schemes and gross revenue for Vitality Group Core new business API to R9 916m Normalised operating profit to R4 507m Normalised headline earnings to R2 284m COVID-19 provisions Headline earnings to R1 842m unchanged SA COMPOSITE MODEL UK COMPOSITE MODEL PARTNER COMPOSITE MODEL Health Life Invest Robust operating performance with prudent COVID-19 provision Operating model performing well and driving growth, with strength in capital and liquidity A pivot to growth following trends emerging through COVID-19 The businesses well positioned in the four strategic strands -- 84 of 85 -- 85 85 for the six months ended 31 December 2020 -- 85 of 85 --